US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arch Biopartners Inc.

1.19

-0.0340-2.79%

Volume:29.41K

Turnover:35.15K

Market Cap:78.40M

PE:-25.67

High:1.24

Open:1.24

Low:1.17

Close:1.22

52wk High:1.52

52wk Low:1.04

Shares:66.11M

Float Shares:50.06M

Volume Ratio:0.98

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0462

EPS(LYR):-0.0434

ROE:142.78%

ROA:-136.48%

PB:-29.64

PE(LYR):-27.34

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Arch Biopartners Inc.

Exchange:

OTCQB

Establishment Date:

- -

Employees:

- -

Office Location:

545 King Street West,Toronto,Ontario,Canada

Website:

http://www.archbiopartners.com

Zip Code:

M5V 1M1

Phone:

Fax:

- -

Introduction:

Arch Biopartners Inc., together with its subsidiaries, engages in the development of therapeutic drugs for inflammation and acute organ injuries in Canada. It focuses on developing its lead drug candidate LSALT Peptide, a product in Phase 2 clinical trials to treat dipeptidase-1 mediated organ inflammation in the lungs, liver, and kidneys. The company also develops AB569 for treating antibiotic-resistant bacterial infections, and for the treatment of wounds; and Borg, a peptide-solid surface interface to reduce corrosion of metals. Arch Biopartners Inc. is based in Toronto, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACHFF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACHFF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACHFF\",,,,,undefined,":{"symbol":"ACHFF","market":"US","secType":"STK","nameCN":"Arch Biopartners Inc.","latestPrice":1.186,"timestamp":1757009528101,"preClose":1.22,"halted":0,"volume":29410,"delay":15,"floatShares":50064327,"shares":66106366,"eps":-0.046206,"marketStatus":"Trading","change":-0.034,"latestTime":"09-04 14:12:08 EDT Delay","open":1.235,"high":1.235,"low":1.17,"amount":35145.076,"amplitude":0.053279,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.046206,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1757016000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":1.22,"volumeRatio":0.984016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACHFF\",,,,,undefined,":{"symbol":"ACHFF","floatShares":50064327,"roa":"-136.48%","roe":"142.78%","lyrEps":-0.043386,"volumeRatio":0.984016,"shares":66106366,"dividePrice":0,"high":1.235,"amplitude":0.053279,"preClose":1.22,"low":1.17,"week52Low":1.04,"pbRate":"-29.64","psRate":"-1279.74","week52High":1.5225,"institutionHeld":0,"latestPrice":1.186,"eps":-0.046206,"divideRate":0,"volume":29410,"delay":15,"ttmEps":-0.046206,"open":1.235,"prevYearClose":1.35,"prevWeekClose":1.213,"prevMonthClose":1.213,"prevQuarterClose":1.3,"fiveDayClose":1.22,"twentyDayClose":1.23,"sixtyDayClose":1.37},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACHFF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-29","symbol":"ACHFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1724904000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-30","symbol":"ACHFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1717041600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-02-28","symbol":"ACHFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709096400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-01-29","symbol":"ACHFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1706504400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-08-29","symbol":"ACHFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1693281600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACHFF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACHFF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":30514493,"address":"545 King Street West,Toronto,Ontario,Canada","zipCode":"M5V 1M1","officePhone":"647-428-7031"},"stockCompanyDetail":{"websiteUrl":"http://www.archbiopartners.com","stockEarnings":[{"period":"1week","weight":0.0232},{"period":"1month","weight":-0.0436},{"period":"3month","weight":-0.1573},{"period":"6month","weight":-0.1279},{"period":"1year","weight":-0.3582},{"period":"ytd","weight":-0.1657}],"description":"Arch Biopartners Inc., together with its subsidiaries, engages in the development of therapeutic drugs for inflammation and acute organ injuries in Canada. It focuses on developing its lead drug candidate LSALT Peptide, a product in Phase 2 clinical trials to treat dipeptidase-1 mediated organ inflammation in the lungs, liver, and kidneys. The company also develops AB569 for treating antibiotic-resistant bacterial infections, and for the treatment of wounds; and Borg, a peptide-solid surface interface to reduce corrosion of metals. Arch Biopartners Inc. is based in Toronto, Canada.","exchange":"OTCQB","name":"Arch Biopartners Inc.","nameEN":"Arch Biopartners Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ACHFF\",market:\"US\",,,undefined,":null}}